Studies using a tamoxifen-inducible Cre recombinase, driven by the P0 promoter to disrupt Nf1 in mSCs, showed that Nf1-/- repair mSCs promote neurofibroma formation at the injured nerve [85]. The gene discussed is NF1; the disease is plexiform neurofibroma.